Medtech company DermaSensor has claimed FDA approval for a handheld device, powered by artificial intelligence (AI), that can be used to detect skin cancer at the point of care. The eponymous device, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback